This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
500mg | $650 | Check With Us |
1g | $1050 | Check With Us |
5g | $2660 | Check With Us |
Cat #: V3921 CAS #: 1197958-12-5 Purity ≥ 98%
Description: Brigatinib analog is a derivative of Brigatinib (AP-26113; Alunbrig), which is an orally bioavailable ALK (anaplastic lymphoma kinase) inhibitor approved by FDA in 2017 for the treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC).
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 529.01 |
---|---|
Molecular Formula | C26H34ClN6O2P |
CAS No. | 1197958-12-5 |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent | |
Solubility In Vitro | DMSO: 45 mg/mL (85.1 mM)r |
Water: <1 mg/mLr | |
Ethanol: 106 mg/mL (200.4 mM) | |
Solubility In Vivo | NMP+polyethylene glycol 300 (10+90, v+v): 1 mg/mL |
SMILES Code | CP(C)(C1=CC=CC=C1NC2=NC(NC3=CC=C(N4CCC(N(C)C)CC4)C=C3OC)=NC=C2Cl)=O |
Synonyms | AP-26113; Brigatinib-analog; AP26113; AP 26113 |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 1.8903 mL | 9.4516 mL | 18.9032 mL | 37.8065 mL |
5mM | 0.3781 mL | 1.8903 mL | 3.7806 mL | 7.5613 mL |
10mM | 0.1890 mL | 0.9452 mL | 1.8903 mL | 3.7806 mL |
20mM | 0.0945 mL | 0.4726 mL | 0.9452 mL | 1.8903 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.